Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment
David J. King(Regulus Therapeutics (United States)), G. T. Yarranton(Celltechgen (United States)), Dominic Löw(UCB Pharma (United Kingdom)), John R. Adair(UCB Pharma (United Kingdom)), J. C. Lloyd(UCB Pharma (United Kingdom)), Sarojani Angal(Cell Technology (China)), Mark Bodmer(UCB Pharma (United Kingdom)), K. Proudfoot(UCB Pharma (United Kingdom))
Cited by 76
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
|PubMed|1996|212
Studies on lipid peroxidation in normal and tumour tissues. The Novikoff rat liver tumour
|Biochemical Journal|1986|130
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
|Protein Engineering Design and Selection|1994|122